Cancer-associated fibroblasts drive immune resistance in MSS colorectal cancer via the FAIM2-CES1-ER stress pathway
Ren Tang, Hongtao Wan, Menglan Zhong, Kangpeng Yan, Bin Xu, Jianyong Xiong · 2026
Read Cancer-associated fibroblasts drive immune resistance in MSS colorectal cancer via the FAIM2-CES1-ER stress pathway by Ren Tang, Hongtao Wan, Menglan Zhong, Kangpeng Yan, Bin Xu, Jianyong Xiong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13687333.txt.
Description
Ren Tang and co-authors study why a common bowel cancer type resists immune therapy in a 2026 paper. The type, called MSS colorectal cancer, often sits in a fibrous, immune suppressing setting and responds poorly to checkpoint drugs. Support cells around the tumor, known as fibroblasts, reshape its matrix, but the controls on them were unclear.
A gene called FAIM2 was found lowered in this cancer and tied to immune entry and patient outlook. It sits mostly in those support cells and runs opposite to collagen output. Raising it in cells cut stress signals and collagen, while lowering it did the reverse. A second gene carried the effect, and raising FAIM2 slowed tumors in animals.
Catalog record
| CREATOR | Ren Tang, Hongtao Wan, Menglan Zhong, Kangpeng Yan, Bin Xu, Jianyong Xiong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |